[333 Pages Report] The global pupillometer market is projected to have a moderate-paced CAGR of 7.7% during the forecast period. The current valuation of the pupillometer market is US$ 385.56 Million in 2023. The value of the pupillometer market is anticipated to reach a high of US$ 809.56 Million by the year 2033.
This growth in the sales of pupillometer is supported by the following:
| Attribute | Details |
|---|---|
| Market Value (2023) | US$ 385.56 Million |
| Market Value (2033) | US$ 809.56 Million |
| CAGR | 7.7% |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
When comparing digital and video pupillometers, the latter is clearly superior. To give just one example, these tools can record the full range of pupillary responses. In addition, video pupillometers like Konan Medical USA Inc.'s EyeKinetix pupillometer use infrared high-definition video cameras to record the bilateral pupil responses to monocular visual stimuli.
Additionally, EyeKinetix captures both spontaneous and evoked pupillary light reactions at the same time. Another element contributing to increased interest in video automated pupillometer is their recent regulatory clearance. So, in July 2021, NeurOptics Inc. introduced the NPi-300 Pupillometer to consumers in the United States. The NPI-300 Pupillometer also contains cutting-edge technologies like an LED light source, a high-precision infrared camera, and a powerful microprocessor. As a result, the market expands as a result of the increased demand brought about by these features.
In addition, video pupillometers like the NPi-300 are faster and more convenient than digital pupillometers. Therefore, automatic pupillometers eliminate the potential for human error that might occur with manual approaches. Consequently, this causes an increase in demand for video pupillometers, which in turn propels the development of the market. Therefore, because of these benefits, these devices are widely used in clinical practice.
The pupillometer market is expanding as a result of the widespread use of computers and the Internet in the creation of brand-new goods. For instance, in 2017, Essilor Instruments USA introduced the X81705 Pupillometer medical device, which combines precise measurement with user-friendly controls. Binocular and monocular measures, as well as the X81705's infinite vision distance setting, are both fully manually adjustable. The X81705 also has an automatic off/on functionality and digital readouts that can measure down to 0.5 nm.
The automated pupillometer market is expanding as more people seek alternatives to the traditional method of pupil measurement due to safety concerns. As an example, a 2016 study published in the American Journal of Critical Care found that neurological nurses and critical care consistently underestimated pupil size and incorrectly measured pupil reactivity, leading the authors to conclude that the use of an automated pupillometer medical device is an essential tool allowing for more effective and timely diagnostics.
The rising global incidence of eye problems is also fuelling demand for pupillometers. The number of people with moderate or severe visual impairment is projected to increase to nearly 588 million by 2050 from the current estimate of 217 million, according to 2017 research by the International Council of Ophthalmology.
The demand for pupillometers is expanding because of the rise in ophthalmic-related illnesses caused by prolonged use of digital electronics such as TVs, smartphones & tablets, laptops, video games, and PCs. While demand for pupilometers continues to rise, the market expansion is being stymied by a dearth of trained personnel to operate cutting-edge devices.
Principal Consultant
| Market Share (2033) | 26.3% |
|---|
The US market is expected to hold a market share of 26.3% of the global market.
In 2021, North America accounted for over 26.3% of global revenue, thanks to the region's large population and high incidence of neurological and eye illnesses. Pupillometry's widespread applicability in the United States is another factor that should boost sales.
The United States is home to several market leaders, including NeurOptics, a company that designs and manufactures state-of-the-art pupillometers to improve medical diagnostics. The company is also investigating the application of pupillometers across a range of critical care settings to broaden the scope of its products.
| Market Growth Rate (2023 to 2033) | 8.8% |
|---|
An 8.8 percent compound annual growth rate (CAGR) is predicted for the Europe Pupillometer Market between 2023 and 2033.
As their use in neuropsychological testing becomes increasingly commonplace, pupillometers are enjoying brisk sales growth around the world. When compared to more conventional approaches, the price of the next-generation pupillometer is higher. Despite the advantages of medical devices, their adoption rate has not changed significantly in industrialized economies.
With the rising prevalence of neurological illnesses, the pupillometer is finding more and more uses. Furthermore, technical development has led to the creation of a pupillometer for the next generation, which is more advanced than the medical devices of the past.
The forecast calls for the fastest growth in Japan for the Asia Pacific region. Pupillometers are becoming more widely available in the region owing to an increase in the number of online retailers and distributors offering them. Pupillometers are also being offered by the regional branches of multinational corporations like NeurOptics, Johnson & Johnson Vision, and Konan Medical.
NeurOptics' pupillometer is available in India through Hansraj Nayyar Medical India, in Japan from IMI Co., and in South Korea from Neuroplus. The introduction of major corporations like NIDEK has boosted the automated pupillometer's accessibility and popularity in the region.
Pupillometry is a growing industry for many reasons, including the prevalence of neurological illnesses. According to The Lancet Global Health Report 2021, for instance, an aging population is a major contributor to the rising incidence of non-communicable neurological illnesses in India. Major causes of disability from neurological disorders in India include stroke, headache problems, and epilepsy. Since automated pupillometers are used to measure eye curvature, which can indicate neurological abnormalities, this drives up demand for the devices. Over the next few years, the market in question is likely to expand, thanks to the rising prevalence of neurological illnesses.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
New Entrants to Foster Innovation in the Global Market
The startups in the pupillometer market are adding a new edge to the properties of excavators by curating innovations beyond the imagination. They are continually upgrading the pupillometer with advanced technology, and manufacturers and sellers are continuously attempting to reduce costs for greater accessibility to the market share. Startup firms are triggering the expansion of the pupillometer market with their unique attempts.
The top startups operating in the market are:
| Name | Mind’s Eye |
|---|---|
| Date of Establishment | 2016 |
| Description | When it comes to pupillometry biomarkers for ADHD, Mind'sEye Diagnostics has you covered. The platform relies on our novel scientific biomarkers, which include the use of a mobile phone camera to extract eye parameters, the execution of unique image analysis, and the deployment of a proprietary analysis algorithm, all of which allow for the identification of ADHD and other mental disorders. There's also a smartphone app that keeps tabs on how a patient's ADHD symptoms change throughout the day, allowing for more precise dosing and better overall management of the condition. |
| Name | EYE-COG |
|---|---|
| Mind’s Eye | 2016 |
| Description | EYE-main COG's goal is to aid in the identification of ADHD and other mental problems using pupillometry biomarkers. It has developed a platform that includes an Eye tracker, a short, computerized attention test, a personal questionnaire, and a cloud-based algorithm that analyses eye markers taken from the eye tracker data and automatically sends a full report to EYE-COG software which can be used for the accurate diagnosis of ADHD. Single ADHD analysis tests can be purchased for $30 each, and the kit can be purchased for $1500. |
There are several international and domestic players in the pupillometer industry, making for a competitive marketplace. NeurOptics Inc., Essilor Group (Essilor Instruments), Visionix, US Ophthalmic., NIDEK SA, HAAG-STREIT GROUP, Reichert Inc., Konan Medical USA Inc., Good-Lite Company, Grobet USA are among the top players in the market (Vigor Optical).
In order to maintain their market share and expand their product offerings, many companies are implementing market strategies like the introduction of new, ground-breaking items as well as mergers, collaborations, and acquisitions.
Some of the recent developments in the pupillometer market include the following:
NeurOptics Inc. introduced the NPi-300 pupillometer in 15 countries in May of 2022. The United Kingdom, France, Italy, Germany, Switzerland, Austria, Norway, Sweden, Denmark, Belgium, the Netherlands, Luxembourg, Ireland, Australia, and New Zealand were among the first to introduce the pupillometer.
The VERITAS Vision System, a next-generation phacoemulsification program (phaco) designed to address three critical areas of patient safety, performance during surgery, and comfort, became globally available on July 23, 2021, thanks to Johnson & Johnson Vision, a global leader in eye health and part of Johnson & Johnson Medical Devices Companies. This weekend at the 2021 American Society of Cataract and Refractive Surgery (ASCRS) and American Society of Ophthalmic Administrators (ASOA) Meeting, the business is expected to provide live demonstrations of the innovative system in the wetland area of Johnson & Johnson.
In the United States, NeurOptics Inc. released the NPi-300 Pupillometer in July 2021. The NPI-300 is an automated pupillometer for use in neurological testing. It is also utilized to detect neurological disorders in both young and old individuals, including stroke, TBI, seizures, and other neurological events.
The growth outlook for the Pupillometer market is predicted to advance at a CAGR of 7.7% from 2022-to 2032.
The North American region is anticipated to lead the Pupillometer market during the forecast period.
The market valuation of the Pupillometer market stands at US$ 385.56 Mn Mn in 2023.
The Pupillometer market is likely to hold a valuation of U US$ 809.56 Mn by 2033.
The kitchen appliances sector is the key driver in the Pupillometer market.
1. Executive Summary | Pupillometer Market
1.1. Global Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Technology Roadmap Analysis
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Background
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity
3.1.4. Trends
3.2. Scenario Forecast
3.2.1. Demand in Optimistic Scenario
3.2.2. Demand in Likely Scenario
3.2.3. Demand in Conservative Scenario
3.3. Opportunity Map Analysis
3.4. Investment Feasibility Matrix
3.5. PESTLE and Porter’s Analysis
3.6. Regulatory Landscape
3.6.1. By Key Regions
3.6.2. By Key Countries
3.7. Regional Parent Market Outlook
4. Global Market Analysis 2017 to 2021 and Forecast, 2022 to 2032
4.1. Historical Market Size Value (US$ Million) Analysis, 2017 to 2021
4.2. Current and Future Market Size Value (US$ Million) Projections, 2022 to 2032
4.2.1. Y-o-Y Growth Trend Analysis
4.2.2. Absolute $ Opportunity Analysis
5. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Mobility
5.1. Introduction / Key Findings
5.2. Historical Market Size Value (US$ Million) Analysis By Mobility, 2017 to 2021
5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Mobility, 2022 to 2032
5.3.1. Table-top
5.3.2. Hand-held
5.4. Y-o-Y Growth Trend Analysis By Mobility, 2017 to 2021
5.5. Absolute $ Opportunity Analysis By Mobility, 2022 to 2032
6. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Type
6.1. Introduction / Key Findings
6.2. Historical Market Size Value (US$ Million) Analysis By Type, 2017 to 2021
6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Type, 2022 to 2032
6.3.1. Video
6.3.2. Digital
6.4. Y-o-Y Growth Trend Analysis By Type, 2017 to 2021
6.5. Absolute $ Opportunity Analysis By Type, 2022 to 2032
7. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By End-Use
7.1. Introduction / Key Findings
7.2. Historical Market Size Value (US$ Million) Analysis By End-Use, 2017 to 2021
7.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By End-Use, 2022 to 2032
7.3.1. Hospitals
7.3.2. Eye Clinics
7.3.3. Others
7.4. Y-o-Y Growth Trend Analysis By End-Use, 2017 to 2021
7.5. Absolute $ Opportunity Analysis By End-Use, 2022 to 2032
8. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Application
8.1. Introduction / Key Findings
8.2. Historical Market Size Value (US$ Million) Analysis By Application, 2017 to 2021
8.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Application, 2022 to 2032
8.3.1. Ophthalmology
8.3.2. Neurology
8.3.3. Oncology
8.3.4. Others
8.4. Y-o-Y Growth Trend Analysis By Application, 2017 to 2021
8.5. Absolute $ Opportunity Analysis By Application, 2022 to 2032
9. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Region
9.1. Introduction
9.2. Historical Market Size Value (US$ Million) Analysis By Region, 2017 to 2021
9.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2022 to 2032
9.3.1. North America
9.3.2. Latin America
9.3.3. Europe
9.3.4. South Asia
9.3.5. East Asia
9.3.6. Oceania
9.3.7. MEA
9.4. Market Attractiveness Analysis By Region
10. North America Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country
10.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2021
10.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032
10.2.1. By Country
10.2.1.1. The US
10.2.1.2. Canada
10.2.2. By Mobility
10.2.3. By Type
10.2.4. By End-Use
10.2.5. By Application
10.3. Market Attractiveness Analysis
10.3.1. By Country
10.3.2. By Mobility
10.3.3. By Type
10.3.4. By End-Use
10.3.5. By Application
10.4. Key Takeaways
11. Latin America Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country
11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2021
11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032
11.2.1. By Country
11.2.1.1. Brazil
11.2.1.2. Mexico
11.2.1.3. Rest of Latin America
11.2.2. By Mobility
11.2.3. By Type
11.2.4. By End-Use
11.2.5. By Application
11.3. Market Attractiveness Analysis
11.3.1. By Country
11.3.2. By Mobility
11.3.3. By Type
11.3.4. By End-Use
11.3.5. By Application
11.4. Key Takeaways
12. Europe Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country
12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2021
12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032
12.2.1. By Country
12.2.1.1. Germany
12.2.1.2. The UK
12.2.1.3. France
12.2.1.4. Spain
12.2.1.5. Italy
12.2.1.6. Rest of Europe
12.2.2. By Mobility
12.2.3. By Type
12.2.4. By End-Use
12.2.5. By Application
12.3. Market Attractiveness Analysis
12.3.1. By Country
12.3.2. By Mobility
12.3.3. By Type
12.3.4. By End-Use
12.3.5. By Application
12.4. Key Takeaways
13. South Asia Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country
13.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2021
13.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032
13.2.1. By Country
13.2.1.1. India
13.2.1.2. Malaysia
13.2.1.3. Singapore
13.2.1.4. Thailand
13.2.1.5. Rest of South Asia
13.2.2. By Mobility
13.2.3. By Type
13.2.4. By End-Use
13.2.5. By Application
13.3. Market Attractiveness Analysis
13.3.1. By Country
13.3.2. By Mobility
13.3.3. By Type
13.3.4. By End-Use
13.3.5. By Application
13.4. Key Takeaways
14. East Asia Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country
14.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2021
14.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032
14.2.1. By Country
14.2.1.1. China
14.2.1.2. Japan
14.2.1.3. South Korea
14.2.2. By Mobility
14.2.3. By Type
14.2.4. By End-Use
14.2.5. By Application
14.3. Market Attractiveness Analysis
14.3.1. By Country
14.3.2. By Mobility
14.3.3. By Type
14.3.4. By End-Use
14.3.5. By Application
14.4. Key Takeaways
15. Oceania Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country
15.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2021
15.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032
15.2.1. By Country
15.2.1.1. Australia
15.2.1.2. New Zealand
15.2.2. By Mobility
15.2.3. By Type
15.2.4. By End-Use
15.2.5. By Application
15.3. Market Attractiveness Analysis
15.3.1. By Country
15.3.2. By Mobility
15.3.3. By Type
15.3.4. By End-Use
15.3.5. By Application
15.4. Key Takeaways
16. MEA Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country
16.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2021
16.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032
16.2.1. By Country
16.2.1.1. GCC Countries
16.2.1.2. South Africa
16.2.1.3. Israel
16.2.1.4. Rest of MEA
16.2.2. By Mobility
16.2.3. By Type
16.2.4. By End-Use
16.2.5. By Application
16.3. Market Attractiveness Analysis
16.3.1. By Country
16.3.2. By Mobility
16.3.3. By Type
16.3.4. By End-Use
16.3.5. By Application
16.4. Key Takeaways
17. Key Countries Market Analysis
17.1. The US
17.1.1. Pricing Analysis
17.1.2. Market Share Analysis, 2021
17.1.2.1. By Mobility
17.1.2.2. By Type
17.1.2.3. By End-Use
17.1.2.4. By Application
17.2. Canada
17.2.1. Pricing Analysis
17.2.2. Market Share Analysis, 2021
17.2.2.1. By Mobility
17.2.2.2. By Type
17.2.2.3. By End-Use
17.2.2.4. By Application
17.3. Brazil
17.3.1. Pricing Analysis
17.3.2. Market Share Analysis, 2021
17.3.2.1. By Mobility
17.3.2.2. By Type
17.3.2.3. By End-Use
17.3.2.4. By Application
17.4. Mexico
17.4.1. Pricing Analysis
17.4.2. Market Share Analysis, 2021
17.4.2.1. By Mobility
17.4.2.2. By Type
17.4.2.3. By End-Use
17.4.2.4. By Application
17.5. Germany
17.5.1. Pricing Analysis
17.5.2. Market Share Analysis, 2021
17.5.2.1. By Mobility
17.5.2.2. By Type
17.5.2.3. By End-Use
17.5.2.4. By Application
17.6. The UK
17.6.1. Pricing Analysis
17.6.2. Market Share Analysis, 2021
17.6.2.1. By Mobility
17.6.2.2. By Type
17.6.2.3. By End-Use
17.6.2.4. By Application
17.7. France
17.7.1. Pricing Analysis
17.7.2. Market Share Analysis, 2021
17.7.2.1. By Mobility
17.7.2.2. By Type
17.7.2.3. By End-Use
17.7.2.4. By Application
17.8. Spain
17.8.1. Pricing Analysis
17.8.2. Market Share Analysis, 2021
17.8.2.1. By Mobility
17.8.2.2. By Type
17.8.2.3. By End-Use
17.8.2.4. By Application
17.9. Italy
17.9.1. Pricing Analysis
17.9.2. Market Share Analysis, 2021
17.9.2.1. By Mobility
17.9.2.2. By Type
17.9.2.3. By End-Use
17.9.2.4. By Application
17.10. India
17.10.1. Pricing Analysis
17.10.2. Market Share Analysis, 2021
17.10.2.1. By Mobility
17.10.2.2. By Type
17.10.2.3. By End-Use
17.10.2.4. By Application
17.11. Malaysia
17.11.1. Pricing Analysis
17.11.2. Market Share Analysis, 2021
17.11.2.1. By Mobility
17.11.2.2. By Type
17.11.2.3. By End-Use
17.11.2.4. By Application
17.12. Singapore
17.12.1. Pricing Analysis
17.12.2. Market Share Analysis, 2021
17.12.2.1. By Mobility
17.12.2.2. By Type
17.12.2.3. By End-Use
17.12.2.4. By Application
17.13. Thailand
17.13.1. Pricing Analysis
17.13.2. Market Share Analysis, 2021
17.13.2.1. By Mobility
17.13.2.2. By Type
17.13.2.3. By End-Use
17.13.2.4. By Application
17.14. China
17.14.1. Pricing Analysis
17.14.2. Market Share Analysis, 2021
17.14.2.1. By Mobility
17.14.2.2. By Type
17.14.2.3. By End-Use
17.14.2.4. By Application
17.15. Japan
17.15.1. Pricing Analysis
17.15.2. Market Share Analysis, 2021
17.15.2.1. By Mobility
17.15.2.2. By Type
17.15.2.3. By End-Use
17.15.2.4. By Application
17.16. South Korea
17.16.1. Pricing Analysis
17.16.2. Market Share Analysis, 2021
17.16.2.1. By Mobility
17.16.2.2. By Type
17.16.2.3. By End-Use
17.16.2.4. By Application
17.17. Australia
17.17.1. Pricing Analysis
17.17.2. Market Share Analysis, 2021
17.17.2.1. By Mobility
17.17.2.2. By Type
17.17.2.3. By End-Use
17.17.2.4. By Application
17.18. New Zealand
17.18.1. Pricing Analysis
17.18.2. Market Share Analysis, 2021
17.18.2.1. By Mobility
17.18.2.2. By Type
17.18.2.3. By End-Use
17.18.2.4. By Application
17.19. GCC Countries
17.19.1. Pricing Analysis
17.19.2. Market Share Analysis, 2021
17.19.2.1. By Mobility
17.19.2.2. By Type
17.19.2.3. By End-Use
17.19.2.4. By Application
17.20. South Africa
17.20.1. Pricing Analysis
17.20.2. Market Share Analysis, 2021
17.20.2.1. By Mobility
17.20.2.2. By Type
17.20.2.3. By End-Use
17.20.2.4. By Application
17.21. Israel
17.21.1. Pricing Analysis
17.21.2. Market Share Analysis, 2021
17.21.2.1. By Mobility
17.21.2.2. By Type
17.21.2.3. By End-Use
17.21.2.4. By Application
18. Market Structure Analysis
18.1. Competition Dashboard
18.2. Competition Benchmarking
18.3. Market Share Analysis of Top Players
18.3.1. By Regional
18.3.2. By Mobility
18.3.3. By Type
18.3.4. By End-Use
18.3.5. By Application
19. Competition Analysis
19.1. Competition Deep Dive
19.1.1. NeurOptics, Inc.
19.1.1.1. Overview
19.1.1.2. Product Portfolio
19.1.1.3. Profitability by Market Segments
19.1.1.4. Sales Footprint
19.1.1.5. Strategy Overview
19.1.1.5.1. Marketing Strategy
19.1.2. Adaptica
19.1.2.1. Overview
19.1.2.2. Product Portfolio
19.1.2.3. Profitability by Market Segments
19.1.2.4. Sales Footprint
19.1.2.5. Strategy Overview
19.1.2.5.1. Marketing Strategy
19.1.3. Essilor Instruments USA
19.1.3.1. Overview
19.1.3.2. Product Portfolio
19.1.3.3. Profitability by Market Segments
19.1.3.4. Sales Footprint
19.1.3.5. Strategy Overview
19.1.3.5.1. Marketing Strategy
19.1.4. HAAG-STREIT GROUP
19.1.4.1. Overview
19.1.4.2. Product Portfolio
19.1.4.3. Profitability by Market Segments
19.1.4.4. Sales Footprint
19.1.4.5. Strategy Overview
19.1.4.5.1. Marketing Strategy
19.1.5. Johnson & Johnson Vision
19.1.5.1. Overview
19.1.5.2. Product Portfolio
19.1.5.3. Profitability by Market Segments
19.1.5.4. Sales Footprint
19.1.5.5. Strategy Overview
19.1.5.5.1. Marketing Strategy
19.1.6. Luneau Technology Group
19.1.6.1. Overview
19.1.6.2. Product Portfolio
19.1.6.3. Profitability by Market Segments
19.1.6.4. Sales Footprint
19.1.6.5. Strategy Overview
19.1.6.5.1. Marketing Strategy
19.1.7. NIDEK CO., LTD.
19.1.7.1. Overview
19.1.7.2. Product Portfolio
19.1.7.3. Profitability by Market Segments
19.1.7.4. Sales Footprint
19.1.7.5. Strategy Overview
19.1.7.5.1. Marketing Strategy
19.1.8. Reichert Technologies
19.1.8.1. Overview
19.1.8.2. Product Portfolio
19.1.8.3. Profitability by Market Segments
19.1.8.4. Sales Footprint
19.1.8.5. Strategy Overview
19.1.8.5.1. Marketing Strategy
19.1.9. SCHWIND eye-tech-solutions
19.1.9.1. Overview
19.1.9.2. Product Portfolio
19.1.9.3. Profitability by Market Segments
19.1.9.4. Sales Footprint
19.1.9.5. Strategy Overview
19.1.9.5.1. Marketing Strategy
19.1.10. US Ophthalmic
19.1.10.1. Overview
19.1.10.2. Product Portfolio
19.1.10.3. Profitability by Market Segments
19.1.10.4. Sales Footprint
19.1.10.5. Strategy Overview
19.1.10.5.1. Marketing Strategy
19.1.11. Konan Medical
19.1.11.1. Overview
19.1.11.2. Product Portfolio
19.1.11.3. Profitability by Market Segments
19.1.11.4. Sales Footprint
19.1.11.5. Strategy Overview
19.1.11.5.1. Marketing Strategy
19.1.12. bright lamp, Inc.
19.1.12.1. Overview
19.1.12.2. Product Portfolio
19.1.12.3. Profitability by Market Segments
19.1.12.4. Sales Footprint
19.1.12.5. Strategy Overview
19.1.12.5.1. Marketing Strategy
20. Assumptions & Acronyms Used
21. Research Methodology
Explore Healthcare Insights
View Reports
Pupillometer Market
